BIM
DRTX

BlackRock Investment Management’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

BlackRock Investment Management’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-45,447
Closed -$576K – 4188
2014
Q3 		$576K Buy
45,447
+521
+1% +$7.78K ﹤0.01% 2895
2014
Q2 		$765K Buy
44,926
+8,525
+23% +$127K ﹤0.01% 2800
2014
Q1 		$490K Buy
36,401
+702
+2% +$9.2K ﹤0.01% 2963
2013
Q4 		$457K Sell
35,699
-1,282
-3% -$13.4K ﹤0.01% 2994
2013
Q3 		$334K Buy
36,981
+2,853
+8% +$23.7K ﹤0.01% 3089
2013
Q2 		$246K Buy
+34,128
New +$251K ﹤0.01% 3125

BlackRock Investment Management's DRTX Position: Q4 2014 in Review

BlackRock Investment Management sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 45,447 shares — an estimated $576K sold.

BlackRock Investment Management first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $765K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • BlackRock Investment Management reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • BlackRock Investment Management sold 45,447 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $576K.
  • BlackRock Investment Management first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • BlackRock Investment Management's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $765K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on BlackRock Investment Management's 13F filing for Q4 2014, filed 9 Feb 2015.